COPD — UKMLA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Limit access to company, research or non-core NHS funding
The best answer is “Limit access to company, research or non-core NHS funding”. NICE HTG779 concludes that evidence is currently insufficient for NHS funding of EchoConfidence, EchoGo Heart Failure, Ligence Heart and Us2.ai. More research is required on diagnostic accuracy, effects on clinical decision making and downstream resource use. Local validation or clinician sign-off does not convert that research-only funding position into routine commissioning.
Reference: NICE HTG779, Artificial intelligence technologies to help detect, diagnose and monitor heart failure: https://www.nice.org.uk/guidance/htg779/chapter/1-Recommendations